Multistage signal-interactive nanoparticles improve tumor targeting through efficient nanoparticle-cell...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Drug Delivery

Background:

• Biological component communication is vital for homeostasis.
• Therapeutic nanoparticles (NPs) often lack communication, leading to clearance and limited tumor accumulation.
• Existing NPs struggle with cellular interaction, impacting therapeutic efficacy.

Purpose of the Study:

• To engineer a multistage signal-interactive system for therapeutic nanoparticles.
• To enhance NP communication with the cellular environment for improved homeostasis and therapeutic outcomes.
• To overcome limitations of current NPs, including macrophage-mediated clearance and poor tumor targeting.

Main Methods:

• Developed a signal-interactive system on porous silicon particles.
• Integrated Self-peptide and Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide for a hierarchical chimeric signaling interface.
• Incorporated "don't eat me" and "eat me" signals for controlled cellular interaction.
• Utilized amantadine for NP transformation and signal conversion via reversible self-mimicking.

Main Results:

• Signal-interactive NPs demonstrated improved tumor targeting (2.8-fold increase).
• Enhanced tumor suppression was observed (6.5-fold increase) compared to non-interactive controls.
• Reduced liver accumulation (51%) and restricted hepatic injury were noted with the novel NPs.

Conclusions:

• The developed biochemical transceiver system effectively enhances NP-cellular communication.
• Signal-interactive NPs show significant potential for improved cancer therapy by optimizing drug delivery and minimizing side effects.
• This approach offers a new strategy for designing autonomous therapeutic nanoparticles with enhanced targeting and reduced toxicity.